DALLAS, Nov. 8, 2012 /PRNewswire/ -- Aprima Medical Software announced today that it has reached a mutually agreeable settlement in the lawsuit brought on October 19, 2012 by Allscripts Healthcare Solutions, LLC. In that lawsuit, Allscripts alleged that some of Aprima's advertising copy violated various state and federal laws. The parties reached an amicable resolution and will continue pursuing their respective business goals. Under the settlement terms, Aprima has modified some of the advertising copy associated with its Aprima Rescue Plan™ for those who currently use the Allscripts MyWay™ product, and who may be looking to replace that product in light of Allscripts' October 3 announcement about its future.
Allscripts MyWayTM is the EHR product offered by Allscripts that it has opted not to develop or update to be in compliance with government incentives and requirements such as Meaningful Use and ICD-10.
The Aprima Rescue PlanTM remains in place for customers of Allscripts MyWayTM. Many believe this program – and Aprima's EHR and PM products – to be the most practical and viable option for providers, since the original Allscripts MyWay™ application was based on the source code that Allscripts licensed from Aprima in 2008.
Allscripts MyWay™ resellers and customers can maintain and even strengthen their current business relationships. Aprima is offering an easy upgrade for practices that may feel frustrated by Allscripts' announcement about MyWay™ and anxious – or even outraged – about the prospect of a potentially expensive conversion if they want to demonstrate 5010 and ICD-10 compliance, or qualify for government incentives including Meaningful Use Stage 2, PQRS, e-Prescribing, and others.
Providers who bought Allscripts MyWay™ for a specific reason, such as the unique non-template approach to charting, the speed and ease-of-use, and the adaptive learning feature, are typically averse to having to change to something that is very different.
Aprima Rescue PlanTM for customers of Allscripts MyWayTM includes:
Aprima is pleased to be able to offer a lifeline to these users for minimal cost and with virtually no downtime. This will circumvent the need for Allscripts MyWayTM users to switch to another Allscripts EMR product, which would require a change in systems, plus a potentially arduous data conversion and retraining period, thus creating additional mental, physical and financial disruption to the practice.
"Ironically, Allscripts MyWayTM users can avoid such a potentially expensive and disruptive situation by switching to Aprima instead of another Allscripts product. We welcome these customers to the Aprima family and we are thrilled to be able to easily upgrade our 'cousins' to the Aprima way," said Aprima president and CEO Michael Nissenbaum. "The difference between a conversion and a simple and proven upgrade can also make the difference on whether practices will achieve compliance on important healthcare initiatives. We are very pleased with the outcome of this legal situation."
About Aprima Medical Software, Inc.
Aprima provides innovative electronic health record, practice management and revenue cycle management solutions for medical practices. The Aprima EHR/PM is an integrated system built on a single database. Aprima uses a fast, flexible design that adapts automatically to a physician's workflow and sets the benchmark for ease-of-use, speed and flexibility. Aprima is one of the few companies with a 14-year track record of success, including CCHIT Certification consistently every year as well as ONC Certification for 2011/2012. Thousands of Aprima users are benefiting from improved quality of care, improved patient satisfaction, improved quality of life and an improved bottom line. Based in Carrollton, TX, Aprima performs all development, support, and implementation from the U.S. To learn more about how Aprima can help your practice, please visit www.aprima.com, call us at 866-960-6890, option 7, or email us at firstname.lastname@example.org.
|SOURCE Aprima Medical Software, Inc.|
Copyright©2012 PR Newswire.
All rights reserved